{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:33:32Z","timestamp":1786577612343,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ejps.2016.12.043","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T03:01:31Z","timestamp":1483671691000},"page":"56-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["An innovative polysaccharide nanobased nail formulation for improvement of onychomycosis treatment"],"prefix":"10.1016","volume":"100","author":[{"given":"Fernanda C.","family":"Flores","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta S.","family":"Rosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruy C.R.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane B.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2016.12.043_bb0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1468-3083.2004.00988.x","article-title":"Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy","volume":"19","author":"Baran","year":"2005","journal-title":"J. Eur. Acad. Dermatol."},{"key":"10.1016\/j.ejps.2016.12.043_bb0010","series-title":"Nanocosmetics and Nanomedicines: New Approaches for Skin Care","author":"Beck","year":"2011"},{"key":"10.1016\/j.ejps.2016.12.043_bb0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijpharm.2012.04.060","article-title":"Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: in vitro and pharmacokinetics studies","volume":"432","author":"Bhatta","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.12.043_bb0020","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/jcla.21973","article-title":"Causative agents of onychomycosis: a 7year study","volume":"30","author":"Chadeganipour","year":"2016","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.ejps.2016.12.043_bb0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00253-011-3477-y","article-title":"Pullulan: biosynthesis, production, and applications","volume":"92","author":"Cheng","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejps.2016.12.043_bb0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2016.12.043_bb0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0958-2592(97)90007-9","article-title":"In vitro study to establish the efficacy of 28% tioconazole solution (Trosyl) against Trichophyton rubrum and Candida albicans","volume":"7","author":"Cryer","year":"1997","journal-title":"Foot"},{"key":"10.1016\/j.ejps.2016.12.043_bb0040","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejps.2013.04.018","article-title":"Pullulan-based nanoparticles as carriers for transmucosal protein delivery","volume":"50","author":"Dion\u00edsio","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2016.12.043_bb0045","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1468-3083.2005.01281.x","article-title":"Epidemiology and clinical classification of onychomycosis","volume":"19","author":"Effendy","year":"2005","journal-title":"J. Eur. Acad. Dermatol."},{"key":"10.1016\/j.ejps.2016.12.043_bb0050","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jconrel.2014.11.017","article-title":"Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective","volume":"199","author":"Elsayed","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2016.12.043_bb0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0378-5173(97)00194-4","article-title":"Poly(e-caprolacton) nanospheres as an alternative way to reduce amphotericin B toxicity","volume":"158","author":"Espuelas","year":"1997","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.12.043_bb0060","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0378-5173(89)90281-0","volume":"55","author":"Fessi","year":"1989","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.12.043_bb0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11046-013-9622-7","article-title":"Antifungal activity of nanocapsule suspensions containing tea tree oil on the growth of Trichophyton rubrum","volume":"175","author":"Flores","year":"2013","journal-title":"Mycopathologia"},{"key":"10.1016\/j.ejps.2016.12.043_bb0070","first-page":"1","article-title":"Mucoadhesive amphiphilic methacrylic copolymer-functionalized poly(-caprolactone) nanocapsules for nose-to-brain delivery of olanzapine","volume":"11","author":"Fonseca","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ejps.2016.12.043_bb0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/CMR.1.2.187","article-title":"Overview of medically important antifungal azole derivatives","volume":"1","author":"Fromtling","year":"1988","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejps.2016.12.043_bb0080","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0738-081X(97)00057-6","article-title":"Medication-induced contact reactions","volume":"15","author":"Guin","year":"1997","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.ejps.2016.12.043_bb0085","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejps.2007.07.009","article-title":"Effect of hydration on the permeation of ketonazole through human nail plate in vitro","volume":"32","author":"Gunt","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2016.12.043_bb0090","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.det.2006.03.010","article-title":"Therapies for onychomycosis: a review","volume":"24","author":"Gupta","year":"2006","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.ejps.2016.12.043_bb0095","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/1061186X.2010.504268","article-title":"Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery pages","volume":"19","author":"Gupta","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejps.2016.12.043_bb0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/117739280700200002","article-title":"Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications","volume":"2","author":"Guterres","year":"2007","journal-title":"Drug Target Insights"},{"key":"10.1016\/j.ejps.2016.12.043_bb0105","first-page":"996","article-title":"Development of a method for determination of tioconazole associated with polymeric nanocapsules by liquid chromatography","volume":"37","author":"H\u00e4rter","year":"2014","journal-title":"Quim Nova"},{"key":"10.1016\/j.ejps.2016.12.043_bb0110","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jaad.2010.09.730","article-title":"Onychomycosis: a proposed revision of the clinical classification","volume":"65","author":"Hay","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejps.2016.12.043_bb0115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2011.07.002","article-title":"\u201cNanoantibiotics\u201d: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era","volume":"156","author":"Huh","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2016.12.043_bb0120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11046-009-9212-x","article-title":"Candidal onychomycosis: a mini-review","volume":"168","author":"Jayatilake","year":"2009","journal-title":"Mycopathologia"},{"key":"10.1016\/j.ejps.2016.12.043_bb0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijbiomac.2016.04.070","article-title":"Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone","volume":"89","author":"Kalam","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejps.2016.12.043_bb0130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0278-6915(85)90030-4","article-title":"Hen's egg chorioallantoic membrane test for irritation potential","volume":"23","author":"Lupke","year":"1985","journal-title":"Chem. Toxicol."},{"key":"10.1016\/j.ejps.2016.12.043_bb0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.colsurfb.2011.05.050","article-title":"Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system","volume":"88","author":"Mohammadi","year":"2011","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.ejps.2016.12.043_bb0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1081\/DDC-43935","article-title":"In vitro transungual permeation of ciclopirox from a hydroxypropyl chitosan-based, watersoluble nail lacquer","volume":"31","author":"Monti","year":"2005","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2016.12.043_bb0145","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.addr.2007.04.012","article-title":"Nanostructured lipid carriers (NLC) in cosmetic dermal products","volume":"59","author":"M\u00fcller","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2016.12.043_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(01)00989-9","article-title":"Drug delivery to the nail following topical application","volume":"236","author":"Murdan","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.12.043_bb0155","series-title":"Topical Nail Products and Ungual Drug Delivery","first-page":"1","article-title":"The nail: anatomy, physiology, diseases, and treatment","author":"Murdan","year":"2013"},{"key":"10.1016\/j.ejps.2016.12.043_bb0160","series-title":"Topical Nail Products and Ungual Drug Delivery","author":"Murthy","year":"2013"},{"key":"10.1016\/j.ejps.2016.12.043_bb0165","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10156-002-0192-8","article-title":"Experimental tinea unguium model to assess topical antifungal agents using the infected human nail with dermatophyte in vitro","volume":"8","author":"Nakashima","year":"2002","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.ejps.2016.12.043_bb0170","first-page":"25","article-title":"Formulation and evaluation of paracetamol tablets manufactured using the dried fruit of Phoenix dactylifera Linn as an excipient","volume":"2","author":"Ngwuluka","year":"2010","journal-title":"Res. Pharm. Biotechnol."},{"key":"10.1016\/j.ejps.2016.12.043_bb0175","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1039\/C2SM26959G","article-title":"An algorithm to determine the mechanism of drug distribution in lipid-core nanocapsule formulations","volume":"9","author":"Oliveira","year":"2013","journal-title":"Soft Matter"},{"key":"10.1016\/j.ejps.2016.12.043_bb0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijpharm.2007.10.009","article-title":"Voriconazole into PLGA nanoparticles: Improving agglomeration and antifungal efficacy","volume":"352","author":"Peng","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2016.12.043_bb0185","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.msec.2015.10.035","article-title":"Spay-dried powders improve the controlled release of antifungal tioconazole-loaded nanocapsules compared to lyophilized products","volume":"59","author":"Ribeiro","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ejps.2016.12.043_bb0190","first-page":"1389","article-title":"Evaluation of the spreadability of pharmaceutical or cosmetic semisolid formulation using scanned imaged","volume":"31","author":"Rigo","year":"2012","journal-title":"Lat. Am. J. Pharm."},{"key":"10.1016\/j.ejps.2016.12.043_bb0195","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.powtec.2010.02.035","article-title":"Effect of lipid nanoparticles containing fatty alcohols having different chain length on the ex vivo skin permeability of Econazole nitrate","volume":"201","author":"Sanna","year":"2010","journal-title":"Powder Technol."},{"key":"10.1016\/j.ejps.2016.12.043_bb0200","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.msec.2014.10.011","article-title":"Dithranol-loaded lipid-core nanocapsules improve the photostability and reduce the in-vitro irritation potential of this drug","volume":"46","author":"Savian","year":"2015","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ejps.2016.12.043_bb0205","series-title":"Topical Nail Products and Ungual Drug Delivery","first-page":"61","article-title":"Topical nail formulations","author":"Shivakumar","year":"2013"},{"key":"10.1016\/j.ejps.2016.12.043_bb0210","series-title":"Desenvolvimento tecnol\u00f3gico e avalia\u00e7\u00e3o de penetra\u00e7\u00e3o cut\u00e2nea de benzofenona-3 a partir de nanoc\u00e1psulas revestidas com quitosana. (Disserta\u00e7\u00e3o de Mestrado)","author":"Siqueira","year":"2008"},{"key":"10.1016\/j.ejps.2016.12.043_bb0215","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000323273","article-title":"Innovative sunscreen formulation based on Benzophenone-3-loaded chitosan-coated polymeric nanocapsules","volume":"24","author":"Siqueira","year":"2011","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.ejps.2016.12.043_bb0220","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0536.1992.tb00285.x","article-title":"Contact allergy to tioconazole","volume":"26","author":"Stubb","year":"1992","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.ejps.2016.12.043_bb0225","series-title":"Martindale: Guia Completa de Consulta F\u00e1rmaco-Terap\u00e9utica","author":"Sweetman","year":"2006"},{"key":"10.1016\/j.ejps.2016.12.043_bb0230","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.addr.2005.07.008","article-title":"Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems","volume":"57","author":"Takeuchi","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2016.12.043_bb0235","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jconrel.2012.05.037","article-title":"PLGA nanoparticles and nanosuspensions with amphotericin B: potent in vitro and in vivo alternatives to Fungizone and AmBisome","volume":"161","author":"Ven","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2016.12.043_bb0240","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejps.2015.08.016","article-title":"Co-encapsulation of imiquimod and copaiba oil in novel nanostructured systems: promising formulations against skin carcinoma","volume":"79","author":"Venturini","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2016.12.043_bb0245","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.clindermatol.2009.12.006","article-title":"Onychomycosis","volume":"28","author":"Welsh","year":"2010","journal-title":"Clin. Dermatol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098716305747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098716305747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T02:37:31Z","timestamp":1568687851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098716305747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":49,"alternative-id":["S0928098716305747"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2016.12.043","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An innovative polysaccharide nanobased nail formulation for improvement of onychomycosis treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2016.12.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}